DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Research exemption
Research exemption
The Hatch-Waxman Act: a Primer
Biotechs Beware: Safe Harbor No More Shawn C
Massachusetts Harm Reduction Commission DATE: January 11, 2019 RE: Follow-Up to January 9, 2019 Meeting
Supreme Court to Clarify Scope - Implications for Stem Cell Research in California Gina C
How the Supreme Court's Decision in Merck V. Integra Fails to Resolve Problems of Judicial Interpretation of 35 U.S.C
Gimme Shelter
Research Use of Patented Knowledge: a Review
Research Exemptions in Patent Law
In-House Research Tools and the Free Testing Safe Harbor from Patent Infringement for Fda-Related Activities
Patent Infringement and Experimental Use Under the Hatch-Waxman Act: Current Issues
Survey of the Safe Harbor in the United States and Europe
Repurposing - Finding New Uses for Old (And Patented) Drugs: Bridging the "Valley of Death," to Translate Academic Research Into New Medicines Daniel S
Was the Fda Exemption to Patent Infringement, 35 Usc
A Comparative Analysis of the Impact of Experimental Use Exemptions in Patent Law on Incentives to Innovate Kevin Iles
Regulatory Justifications: Regulating European Medicines to Maximise Market Potential
A Comparative Analysis of the Impact of Experimental Use Exemptions in Patent Law on Incentives to Innovate Kevin Iles
UPDATE Merck V
The Research and Experimentation Exceptions in Patent Law: Jurisdictional Variations and the WIPO Development Agenda
Top View
Hatch-Waxman Safe Harbor
1 the Political Economy of the Research Exemption in American
The Political Economy of the Research Exemption in American Patent Law
Human Research Protections Manual
The Pharmaceutical Intellectual Property and Competition Law Review
"Early-Working" Exemptions 765
The FDA's Role in the Development of Bioterrorist Countermeasures
Research Tool Patents After Integra V. Merck—Have They Reached a Safe Harbor?
Patenting New Uses for Old Inventions
The Experimental Use Exemptions to Patent Infringement
Christopher Roy-Toole
Reconsidering Experimental Use Rochelle Cooper Dreyfuss
National Assessment Tool to Assist Member States In
Bioterrorism, Influenza, and the Supreme Court's Interpretation of the Research Exemption from Patent Infringement Michael J
623 PATENT INFRINGEMENT in PERSONALIZED MEDICINE: LIMITATIONS of the EXISTING EXEMPTION MECHANISMS Mr. X Suffers from Recurrent
Facilitating Generic Drug Manufacturing: Bolar Exemptions Worldwide
Bringing a Drug to Market in the European Union
In Defense of Stringency